|
0
|
|
Use of tocilizumab for severe hantavirus pulmonary syndrome: a MEURI case series with contextual comparisons.
(linkinghub.elsevier.com)
|
Tortosa F
…
Izcovich A
Lancet Infectious Diseases
2026-06-03
|
#infection
#inflammation
#sepsis
#immunomodulation
#hantavirus
|
|
0
|
|
Ceftazidime-avibactam for multidrug-resistant gram-negative infections: outcomes and timing of initiation across 22 U.S. medical centers.
(journals.asm.org)
|
Kunz Coyne AJ
…
Rybak MJ
Antimicrobial Agents and Chemotherapy
2026-06-03
|
#infection
#amr
#pneumonia
#sepsis
|
|
0
|
|
Population pharmacokinetics and safety of continuous oxacillin in preterm and term neonates and infants.
(journals.asm.org)
|
Lee A
…
Arrieta AC
Antimicrobial Agents and Chemotherapy
2026-06-03
|
#pharmacokinetics
#dosing
#amr
#sepsis
#neonatal
|
|
0
|
|
A multicentre evaluation of pharmacokinetic/pharmacodynamic target attainment of piperacillin and tazobactam and the association with clinical outcomes in critically ill patients with sepsis and septic shock.
(academic.oup.com)
|
Sulaiman H
…
Abdul-Aziz MH
Journal of Antimicrobial Chemotherapy
2026-06-03
|
#pharmacokinetics
#modeling
#dosing
#antibiotic
#sepsis
|